C-reactive protein and its role in the pathogenesis of myocardial infarction

M B Pepys1, G M Hirschfield

  • 1Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London, UK. m.pepys@rfc.ucl.ac.uk

Insights

C-reactive protein (CRP) aids in diagnosing inflammatory conditions. Elevated CRP levels, detected by high-sensitivity assays, now predict cardiovascular events and may be a therapeutic target for atherosclerosis.

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiology

Background:

  • C-reactive protein (CRP) is a classical acute phase reactant.
  • CRP aids in diagnosing and managing infective and inflammatory conditions.
  • High-sensitivity CRP assays strengthen the view of atherosclerosis as an inflammatory disease.

Purpose of the Study:

  • To review the role of CRP in cardiovascular disease.
  • To explore CRP's predictive value for cardiovascular events.
  • To discuss CRP as a potential therapeutic target in atherosclerosis.

Main Methods:

  • Review of existing literature and epidemiological surveys.
  • Analysis of data from studies using high-sensitivity CRP assays.
  • Synthesis of evidence on CRP's role in atherosclerosis pathogenesis.

Main Results:

  • Elevated CRP predicts poor outcomes in unstable coronary syndromes and myocardial infarction.
  • Baseline CRP levels predict future cardiovascular events in at-risk and healthy individuals.
  • Evidence suggests a direct role for CRP in atherosclerosis and post-myocardial infarction inflammation.

Conclusions:

  • CRP is a significant predictor of cardiovascular events.
  • CRP may play a direct role in the pathogenesis of atherosclerosis.
  • CRP presents a potential future therapeutic target for cardiovascular diseases.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...